Waystar (NASDAQ:WAY) Stock: Insider Matthew Hawkins Sells 82,500 Shares

Waystar Holding Corp. (NASDAQ:WAY) CEO Matthew Hawkins sold 82,500 shares of Waystar stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $28.75, for a total value of $2,371,875.00. Following the completion of the sale, the chief executive officer owned 1,804,794 shares of the company’s stock, valued at $51,887,827.50. This trade represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Waystar Trading Down 1.6%

NASDAQ WAY opened at $28.84 on Thursday. Waystar Holding Corp. has a 12 month low of $17.26 and a 12 month high of $37.51. The company has a 50-day moving average of $26.72 and a 200-day moving average of $23.93. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.10 and a quick ratio of 2.10. The company has a market cap of $5.55 billion, a P/E ratio of 41.80, a P/E/G ratio of 1.21 and a beta of 0.11.

Waystar (NASDAQ:WAY) last announced its quarterly earnings data on Monday, November 2nd. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.03. Waystar had a net margin of 10.70% and a return on equity of 6.91%. The business had revenue of $325.62 million for the quarter, compared to analyst estimates of $323.43 million. During the same period in the prior year, the firm posted $0.37 EPS. The company’s revenue was up 21.2% on a year-over-year basis. As a group, equities analysts predict that Waystar Holding Corp. will post 1.43 earnings per share for the current year.

Institutional Trading of Waystar

Institutional investors have recently modified their holdings of the company. Canada Pension Plan Investment Board purchased a new position in Waystar in the second quarter valued at approximately $390,593,000. BlackRock Inc. acquired a new position in Waystar during the second quarter valued at approximately $357,950,000. Advent International L.P. acquired a new stake in shares of Waystar in the second quarter worth $227,060,000. Jupiter Topco LLC acquired a new stake in shares of Waystar in the second quarter worth $58,960,000. Finally, Bank of America Corp DE acquired a new stake in shares of Waystar in the second quarter worth $53,031,000.

Wall Street Analyst Weigh In

A number of research firms have weighed in on WAY. Wolfe Research raised shares of Waystar to an “outperform” rating in a research note on Thursday, August 13th. BMO Capital Markets reissued an “outperform” rating on shares of Waystar in a research note on Thursday, August 27th. KeyCorp boosted their price objective on shares of Waystar from $30.00 to $35.00 and gave the company an “overweight” rating in a research note on Friday, October 16th. Morgan Stanley restated an “equal weight” rating and set a $28.00 price objective on shares of Waystar in a report on Wednesday, September 16th. Finally, Weiss Ratings raised Waystar from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 2nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.23.

About Waystar

Waystar provides cloud-based healthcare payment and revenue cycle management software. Its platform helps healthcare organizations manage administrative and financial processes, including claims submission, payment processing, patient billing, and revenue collection. The company’s products support providers in identifying and addressing claim denials, checking patient eligibility, estimating costs, collecting payments, and analyzing revenue cycle performance. Waystar serves a range of healthcare organizations, including hospitals, health systems, physician groups, and other medical providers, primarily in the United States.